Sio Gene Therapies Current Assets

Sio Gene Therapies (SIOX) currently reports a current assets of $47M as of December 2022. That compares with $90M in the prior-year period — down 47.5% year over year. Use the charts on this page to explore Sio Gene Therapies's current assets history and peer comparisons.

Sio Gene Therapies's current assets decreased from $90M to $47M — a 47.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sio Gene Therapies reported $47M in current assets as of December 2022. That compares with $90M in the prior-year period — down 47.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $47M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sio Gene Therapies, and consider following SIOX for alerts when major investors trade the stock.

Sio Gene Therapies is classified in the Healthcare sector. On current assets, it currently shows $47M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SIOX with unrelated industries.